Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 5
2005 7
2006 8
2007 11
2008 10
2009 7
2010 11
2011 8
2012 6
2013 6
2014 9
2015 5
2016 3
2017 5
2018 3
2019 9
2020 4
2021 4
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for george john in persons
Search for George John Ian Parsons instead (1 results)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ; CIRT Investigators. Ridker PM, et al. N Engl J Med. 2019 Feb 21;380(8):752-762. doi: 10.1056/NEJMoa1809798. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415610 Free PMC article. Clinical Trial.
The final primary end point occurred in 201 patients in the methotrexate group and in 207 in the placebo group (incidence rate, 4.13 vs. 4.31 per 100 person-years; hazard ratio, 0.96; 95% confidence interval [CI], 0.79 to 1.16). The original primary end point occurred in 1 …
The final primary end point occurred in 201 patients in the methotrexate group and in 207 in the placebo group (incidence rate, 4.13 vs. 4.3 …
Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN).
Ranganathan D, Abdul-Aziz MH, John GT, McWhinney BC, Fassett RG, Healy H, Kubler P, Lim A, Lipman J, Purvey M, Roberts M, Reyaldeen R, Ungerer J, Roberts JA. Ranganathan D, et al. Among authors: john gt. Ther Drug Monit. 2019 Dec;41(6):703-713. doi: 10.1097/FTD.0000000000000658. Ther Drug Monit. 2019. PMID: 31219949 Free PMC article. Clinical Trial.
Role of Klotho in aging, phosphate metabolism, and CKD.
John GB, Cheng CY, Kuro-o M. John GB, et al. Am J Kidney Dis. 2011 Jul;58(1):127-34. doi: 10.1053/j.ajkd.2010.12.027. Epub 2011 Apr 15. Am J Kidney Dis. 2011. PMID: 21496980 Free PMC article. Review.
Microbiome-Targeted Therapies as an Adjunct to Traditional Weight Loss Interventions: A Systematic Review and Meta-Analysis.
Peckmezian T, Garcia-Larsen V, Wilkins K, Mosli RH, BinDhim NF, John GK, Yasir M, Azhar EI, Mullin GE, Alqahtani SA. Peckmezian T, et al. Among authors: john gk. Diabetes Metab Syndr Obes. 2022 Dec 11;15:3777-3798. doi: 10.2147/DMSO.S378396. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 36530587 Free PMC article.
CONCLUSION: This analysis indicates that microbiome-targeted supplements may enhance weight loss and other obesity outcomes in adults when delivered as an adjunct to dietary or dietary and exercise interventions. Personalized therapy to include microbiome-targeted suppleme …
CONCLUSION: This analysis indicates that microbiome-targeted supplements may enhance weight loss and other obesity outcomes in adults when d …
Specialized Roles of Human Natural Killer Cell Subsets in Kidney Transplant Rejection.
Kildey K, Francis RS, Hultin S, Harfield M, Giuliani K, Law BMP, Wang X, See EJ, John G, Ungerer J, Wilkinson R, Kassianos AJ, Healy H. Kildey K, et al. Among authors: john g. Front Immunol. 2019 Aug 7;10:1877. doi: 10.3389/fimmu.2019.01877. eCollection 2019. Front Immunol. 2019. PMID: 31440252 Free PMC article.
125 results